IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin

IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin

The mainstay treatment of Clostridium difficile infections (CDI) is antimicrobials with growing support for fecal microbiota transplants. We report the first case of an elderly man with severe refractory NAP-1 pseudomembranous CDI who failed all medical therapy and two fecal transplants with respons...

Full description

Bibliographic Details
Main Authors: Kelley Coffman, Xian Jie Cindy Chen, Charles Okamura, Eddie Louie
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:IDCases
Subjects:
Clostridium difficile infection
C diff
CDI
IVIG
Intravenous immunoglobulin
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250917300070

Internet

http://www.sciencedirect.com/science/article/pii/S2214250917300070

Similar Items